BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1488324)

  • 1. [Effect of long-term hemodialysis on luliberin-induced lutropin secretion in patients with chronic renal failure].
    Starzyk J; Grzeszczak W
    Pol Arch Med Wewn; 1992 Oct; 88(4):238-43. PubMed ID: 1488324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of prolonged hemodialysis therapy on secretion of testosterone induced by luliberin in men with chronic renal insufficiency].
    Starzyk J; Grzeszczak W
    Endokrynol Pol; 1992; 43(2):153-8. PubMed ID: 1345537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of many years of hemodialysis therapy on FSH secretion induced by luliberin in men with chronic renal failure].
    Starzyk J; Grzeszczak W; Kowalski D
    Wiad Lek; 1993 Apr; 46(7-8):286-91. PubMed ID: 8249417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Does a short-term hemodialysis treatment influence function of the pituitary-testicular axis in patients with chronic renal failure?].
    Starzyk J; Grzeszczak W
    Pol Arch Med Wewn; 1993 Jan; 89(1):24-30. PubMed ID: 8479939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsatile bioactive luteinizing hormone secretion in men with chronic renal failure and following renal transplantation.
    Talbot JA; Rodger RS; Robertson WR
    Nephron; 1990; 56(1):66-72. PubMed ID: 2122267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Circadian rhythm of lutropin and follitropin in patients with chronic renal failure].
    Riemel A; Grzeszczak W; Koziak H; Moczulski D
    Pol Arch Med Wewn; 1996 Apr; 95(4):313-22. PubMed ID: 8755837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of long-term erythropoietin (rHuEPO) therapy on the function of the pituitary-gonadal axis in hemodialyzed male patients with end stage renal failure].
    Trembecki J; Kokot F; Wiecek A; Marcinkowski W; Rudka R
    Pol Arch Med Wewn; 1995 Aug; 94(2):144-52. PubMed ID: 8596749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of many years of hemodialysis therapy on hypophyseal-gonadal axis function in males with chronic renal insufficiency].
    Starzyk J; Grzeszczak W
    Pol Tyg Lek; 1996 Feb; 51(6-9):79-81. PubMed ID: 8756737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of blockade of opiate receptors by naloxone on lutropin (LH), follitropin (FSH) and testosterone secretion in patients after kidney transplantation].
    Grzeszczak W; Zukowska-Szczechowska E; Kokot F
    Pol Arch Med Wewn; 1992; 87(4-5):250-7. PubMed ID: 1326100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of gonadectomy and luliberin on the gonadotropic function of the hypophysis in Papio hamadryas].
    Katsiia GV; Gorlushkin VM; Todua TN; Goncharov NP
    Probl Endokrinol (Mosk); 1985; 31(4):55-8. PubMed ID: 3900981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term regulation of LH and FSH secretion in cyclic women. III. Effects of varying doses of two consecutive LH-RH injections on pituitary and ovarian response.
    Römmler A; Viebahn C; Schwartz U; Hammerstein J
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):394-402. PubMed ID: 371321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma gonadotropins after administration of LH-releasing hormone in patients with renal or hepatic failure.
    Schalch DS; Gonzalez-Barcena D; Kastin AJ; Landa L; Lee LA; Zamora MT; Schally AV
    J Clin Endocrinol Metab; 1975 Nov; 41(5):921-5. PubMed ID: 1102555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysine-vasopressin does not affect basal and LH-RH-stimulated LH and FSH release during the menstrual cycle of normal women.
    Chiodera P; Volpi R; Cigarini C; Caiazza A; Marchesi C; Rossi G; Camellini L; Guerra M; Coiro V
    Gynecol Obstet Invest; 1987; 24(1):56-61. PubMed ID: 3114063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory control of the pituitary LH secretion by LH-RH in male rats.
    Sandow J; von Rechenberg W; Kuhl H; Baumann R; Krauss B; Jerzabek G; Kille S
    Horm Res; 1979; 11(6):303-17. PubMed ID: 231566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of luteinizing hormone (LH)-releasing hormone pulse amplitude and frequency on LH secretion by perifused rat anterior pituitary cells.
    Kamel F; Balz JA; Kubajak CL; Schneider VA
    Endocrinology; 1987 Apr; 120(4):1644-50. PubMed ID: 3549266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone-stimulated luteinizing hormone secretion by perifused pituitary cells from normal, gonadectomized, and testicular feminized rats.
    Krieg RJ; Batson JM; Martha PM; Matt DW; Salisbury RL; Evans WS
    Endocrinology; 1990 Jun; 126(6):3022-7. PubMed ID: 2190802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The characteristics of luteinizing hormone and its beta-subunit secretion in dispersed rat anterior pituitary cells.
    Seki T; Makino T; Tanimoto S; Takahashi M; Iida T; Iizuka R
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec; 39(12):2180-4. PubMed ID: 3323364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pulsatile gonadotropin-releasing hormone on the release of luteinizing hormone and follicle-stimulating hormone in vitro by anterior pituitaries from lactating and cycling rats.
    Smith MS
    Endocrinology; 1982 Mar; 110(3):882-91. PubMed ID: 6799281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y potentiates the luteinizing hormone (LH) response to LH-releasing hormone in men.
    Watanobe H; Nigawara T; Anzai J; Sakihara S; Kageyama K; Nasushita R; Sasaki S; Habu S; Takebe K
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1111-7. PubMed ID: 8179590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of GnRH and its antagonist (Antarelix) on LH release from cultured bovine anterior pituitary cells.
    Bellmann A; Schneider F; Kanitz W; Nürnberg G; Tiemann U
    Acta Vet Hung; 2002; 50(1):79-92. PubMed ID: 12061239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.